KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The acquisition of mcePharma, a company focused on the development and production of innovative food supplements, complementary pet feed, and cosmetics, represents a strategic step for the Brenntag Group to strengthen its presence in the Life Sciences market in the EMEA region.
This was already the second successful sale of a company managed by Mr. Mikeš – we previously represented him in the sale of IMCoPharma to the Barentz Group.
Other articles
Chemistry Brings People Together: KŠB at the 2026 Evening of Czech Chemistry
Czech chemistry and the chemical industry are built on innovation, responsibility and the people who drive the field forward. On Thursday, 22 October 2026, leading figures from the field and industry representatives came together at the Grand Hotel International Prague for the Czech Chemical Industry Association’s annual Evening of Czech Chemistry.
KŠB advises Smart Energies Group on transaction supporting wind power development
KŠB has advised Smart Energies Group (SEG) on a transaction with NOHO and innogy Česká republika. The transaction is intended to support the development of wind power in the Pardubice Region and is built on the synergy between wind power generation and battery energy storage.
Pavel Dejl named Czech Republic Lawyer of the Year at the Legal 500 Central & Eastern Europe Awards 2026
We are delighted to announce that KŠB partner Pavel Dejl has been named Czech Republic Lawyer of the Year at the prestigious Legal 500 Central & Eastern Europe Awards 2026.
